Alk-Abello ASWBO:ALKB -1.52%66 Days Inventory is 300.08 as of Mar. 2026, which is 11% above its 10-year median of 269.33. GuruFocus rates WBO:ALKB with a GF Score™ of 66/100 and a GF Value™ of €27.26 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 640 Biotechnology companies, Alk-Abello AS ranks worse than 67.97% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Alk-Abello AS's Average Total Inventories for the
three
months ended in Mar. 2026 was €238.9 Mil. Alk-Abello AS's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €72.6 Mil.
Hence, Alk-Abello AS's Days Inventory for the
three
months ended in Mar. 2026 was 300.08.
The historical rank and industry rank for Alk-Abello AS's Days Inventory or its related term are showing as below:
WBO:ALKB'
s Days Inventory Range Over the Past 10 Years
Min: 216.54 Med: 269.33 Max: 307.3
Current: 301.8
During the past 13 years, Alk-Abello AS's highest Days Inventory was 307.30. The lowest was 216.54. And the median was 269.33.
WBO:ALKB's Days Inventory is ranked worse than 67.97% of 640
companies
in the Biotechnology industry
Industry Median: 184.145
vs WBO:ALKB: 301.80
Alk-Abello AS's Days Inventory
declined
from Mar. 2025 (310.02) to Mar. 2026 (300.08).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Alk-Abello AS's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.30.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Alk-Abello AS's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.01.
Alk-Abello AS (WBO:ALKB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Alk-Abello AS's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Alk-Abello AS's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Alk-Abello AS Days Inventory Related Terms
Alk-Abello AS Days Inventory Historical Data
* Premium members only.
The historical data trend for Alk-Abello AS's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:ALKB vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Alk-Abello AS's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alk-Abello AS Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alk-Abello AS's Days Inventory distribution charts can be found below:
* The bar in red indicates where Alk-Abello AS's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alk-Abello AS (WBO:ALKB) has a Days Inventory of 300.08 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Alk-Abello AS and its competitors. This is 11% above median its historical median of 269.33. Over the past decade, Alk-Abello AS's Days Inventory has ranged from 216.54 to 307.30. According to the industry distribution chart, Alk-Abello AS ranks #435 out of 640 companies in the Biotechnology industry, placing it in the top 68%.
Is Alk-Abello AS's Days Inventory too high?
Alk-Abello AS's current Days Inventory of 300.08 is 11% above median its 10-year median of 269.33. Over the past 10 years, this metric has ranged from a low of 216.54 to a high of 307.30. The Biotechnology industry median Days Inventory is 184.15. Alk-Abello AS's value of 300.08 is 63% above this industry median. Based on the distribution chart, Alk-Abello AS ranks #435 out of 640 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Alk-Abello AS has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Alk-Abello AS ranks #435 out of 640 companies for Days Inventory. This places Alk-Abello AS in the lower half of its industry. The industry median Days Inventory is 184.15. Alk-Abello AS's value of 300.08 is 63% above this benchmark. Historically, Alk-Abello AS's own Days Inventory has ranged from 216.54 to 307.30 over the past decade. While the company's 10-year median is 269.33 vs. the industry median of 184.15, Alk-Abello AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 184.15, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alk-Abello AS's current Days Inventory of 300.08 is 63% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Alk-Abello AS and its competitors. For the Biotechnology industry, the median Days Inventory is 184.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alk-Abello AS's current Days Inventory is 300.08, which is 11% above median its own 10-year median of 269.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (WBO:ALKB) is currently considered Modestly Overvalued. The stock's GF Value™ is €27.26, compared to a current price of €33.70 — trading 23.6% above its estimated fair value. The current Days Inventory is 300.08, which is 11% above median its 10-year median of 269.33 and 63% above the Biotechnology industry median of 184.15. Alk-Abello AS's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Alk-Abello AS (WBO:ALKB), the current Days Inventory is 300.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alk-Abello AS (WBO:ALKB) Overvalued in 2026?
Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued.
The current stock price of €33.70 is trading 23.6% above its estimated GF Value™ of €27.26.
GuruFocus considers Alk-Abello AS to be Modestly Overvalued.
Key valuation signals for WBO:ALKB:
Days Inventory: 300.08 (11% above median its 10-year median of 269.33)
GF Value™: €27.26 vs. price of €33.70 (23.6% above fair value)
Industry Position: 63% above the Biotechnology median (#435 of 640)
No single metric tells the full story. See the WBO:ALKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
66GF Score
Get the complete analysis for WBO:ALKB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ALKB has been successfully added to your 
